We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

277 hedge funds and large institutions have $2.22B invested in Emergent Biosolutions in 2021 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 110 increasing their positions, 96 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more repeat investments, than reductions

Existing positions increased: 110 | Existing positions reduced: 96

2% more call options, than puts

Call options by funds: $5.88M | Put options by funds: $5.79M

0.62% less ownership

Funds ownership: 83.52% → 82.91% (-0.62%)

4% less funds holding

Funds holding: 290 → 277 (-13)

21% less capital invested

Capital invested by funds: $2.8B → $2.22B (-$580M)

30% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 33

Holders
277
Holders Change
-13
Holders Change %
-4.48%
% of All Funds
4.85%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
23
Increased
110
Reduced
96
Closed
33
Calls
$5.88M
Puts
$5.79M
Net Calls
+$91K
Net Calls Change
+$4.43M

Top Buyers

1
Bank of America
Bank of America
North Carolina
+$21.2M
2
GACM
Global Alpha Capital Management
Quebec, Canada
+$20.6M
3
Norges Bank
Norges Bank
Norway
+$19.9M
4
State Street
State Street
Massachusetts
+$16.5M
5
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management
California
+$9.16M

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$47.2M
2
Two Sigma Investments
Two Sigma Investments
New York
-$25.6M
3
AQR Capital Management
AQR Capital Management
Connecticut
-$18.8M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$15.1M
5
Morgan Stanley
Morgan Stanley
New York
-$10.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$292M -$677K -11,185 -0.2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$246M -$2.26M -37,332 -0.8%
Neuberger Berman Group
3
Neuberger Berman Group
New York
$165M -$6.63M -109,544 -3%
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$144M -$47.2M -779,066 -21%
State Street
5
State Street
Massachusetts
$120M +$16.5M +273,127 +13%
EARNEST Partners
6
EARNEST Partners
Georgia
$112M +$7M +115,637 +5%
Manulife (Manufacturers Life Insurance)
7
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$70.1M +$2.91M +48,100 +4%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$49.4M +$649K +10,722 +1%
Northern Trust
9
Northern Trust
Illinois
$46.1M -$1.21M -19,999 -2%
SCM
10
Snyder Capital Management
California
$42.2M +$2.62M +43,331 +5%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$41.2M -$1.2M -19,805 -2%
Invesco
12
Invesco
Georgia
$36.5M -$1.55M -25,522 -3%
Goldman Sachs
13
Goldman Sachs
New York
$35.4M +$3.18M +52,521 +8%
Fidelity Investments
14
Fidelity Investments
Massachusetts
$33.9M -$513K -8,477 -1%
PCM
15
Palisade Capital Management
New Jersey
$32.2M +$2.48M +40,984 +7%
Bank of America
16
Bank of America
North Carolina
$30M +$21.2M +349,327 +140%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$29.8M +$4.34M +71,731 +14%
New York State Common Retirement Fund
18
New York State Common Retirement Fund
New York
$27.7M +$2.77M +45,692 +9%
T. Rowe Price Associates
19
T. Rowe Price Associates
Maryland
$27.1M -$817K -13,487 -2%
Fisher Asset Management
20
Fisher Asset Management
Washington
$26.5M +$2.02M +33,419 +7%
GKIM
21
GW&K Investment Management
Massachusetts
$25M -$292K -4,819 -1%
Charles Schwab
22
Charles Schwab
California
$22.7M -$5.04M -83,282 -16%
ACM
23
Atlanta Capital Management
Georgia
$21.9M -$996K -16,454 -4%
Norges Bank
24
Norges Bank
Norway
$21M +$19.9M +329,150 +365%
Wells Fargo
25
Wells Fargo
California
$20.9M +$7.64M +126,093 +43%
1
2 3 4 5

EBS Hedge Fund Activity: Q3 2021 in Review

277 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q3 2021, worth a combined $2.22B — down 21% from $2.8B a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of EBS and 23 opened new positions — a net loss of 10 holders — while 96 trimmed existing stakes and 110 added.

The largest buyer was Bank of America, adding an estimated $21.2M. The largest seller was Janus Henderson Group, cutting an estimated $47.2M.

  • 277 institutional investors held Emergent Biosolutions (EBS) as of Q3 2021, down from 290 in Q2 2021.
  • Funds reported $2.22B of Emergent Biosolutions stock for Q3 2021, down 21% quarter-over-quarter.
  • 23 funds opened new Emergent Biosolutions positions in Q3 2021 and 33 closed out, a net change of -10 holders.
  • The largest Emergent Biosolutions buyer in Q3 2021 was Bank of America, an estimated $21.2M added.
  • The largest Emergent Biosolutions seller in Q3 2021 was Janus Henderson Group, an estimated $47.2M sold.

Based on aggregated 13F filings for Q3 2021.